ASCL1 and glioma: The study of Rheinbay et al. showed that ASCL1 exerts functions in part by repressing an inhibitor of Wnt signaling, DKK1, resulting in increased signaling through this pathway to maintain the tumorigenicity of glioma cells (Shannon et al., 2003).